These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 15662970)
1. Enhanced cytotoxic effects of 5-aminolevulinic acid-mediated photodynamic therapy by concurrent hyperthermia in glioma spheroids. Hirschberg H; Sun CH; Tromberg BJ; Yeh AT; Madsen SJ J Neurooncol; 2004 Dec; 70(3):289-99. PubMed ID: 15662970 [TBL] [Abstract][Full Text] [Related]
2. Morphological and histological changes of glioma cells immediately after 5-aminolevulinic acid mediated photodynamic therapy. Kamoshima Y; Terasaka S; Kuroda S; Iwasaki Y Neurol Res; 2011 Sep; 33(7):739-46. PubMed ID: 21756554 [TBL] [Abstract][Full Text] [Related]
3. Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids. Madsen SJ; Sun CH; Tromberg BJ; Hirschberg H J Neurooncol; 2003 May; 62(3):243-50. PubMed ID: 12777075 [TBL] [Abstract][Full Text] [Related]
4. Effects of ALA-mediated photodynamic therapy on the invasiveness of human glioma cells. Hirschberg H; Sun CH; Krasieva T; Madsen SJ Lasers Surg Med; 2006 Dec; 38(10):939-45. PubMed ID: 17163479 [TBL] [Abstract][Full Text] [Related]
5. Motexafin gadolinium enhances the efficacy of aminolevulinic acid mediated-photodynamic therapy in human glioma spheroids. Madsen SJ; Mathews MS; Angell-Petersen E; Sun CH; Vo V; Sanchez R; Hirschberg H J Neurooncol; 2009 Jan; 91(2):141-9. PubMed ID: 18777009 [TBL] [Abstract][Full Text] [Related]
6. Acute morphological sequelae of photodynamic therapy with 5-aminolevulinic acid in the C6 spheroid model. Zelenkov P; Baumgartner R; Bise K; Heide M; Meier R; Stocker S; Sroka R; Goldbrunner R; Stummer W J Neurooncol; 2007 Mar; 82(1):49-60. PubMed ID: 17004102 [TBL] [Abstract][Full Text] [Related]
7. The effects of ultra low fluence rate single and repetitive photodynamic therapy on glioma spheroids. Mathews MS; Angell-Petersen E; Sanchez R; Sun CH; Vo V; Hirschberg H; Madsen SJ Lasers Surg Med; 2009 Oct; 41(8):578-84. PubMed ID: 19731298 [TBL] [Abstract][Full Text] [Related]
8. [Photodynamic therapy mediated with 5-aminolevulinic acid for C6 glioma spheroids]. Kamoshima Y; Terasaka S; Iwasaki Y Hokkaido Igaku Zasshi; 2008 May; 83(3):167-73. PubMed ID: 18546870 [TBL] [Abstract][Full Text] [Related]
9. Development of a novel indwelling balloon applicator for optimizing light delivery in photodynamic therapy. Madsen SJ; Sun CH; Tromberg BJ; Hirschberg H Lasers Surg Med; 2001; 29(5):406-12. PubMed ID: 11891728 [TBL] [Abstract][Full Text] [Related]
10. ALA- and ALA-ester-mediated photodynamic therapy of human glioma spheroids. Hirschberg H; Sun CH; Tromberg BJ; Madsen SJ J Neurooncol; 2002 Mar; 57(1):1-7. PubMed ID: 12125962 [TBL] [Abstract][Full Text] [Related]
11. Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model. Angell-Petersen E; Spetalen S; Madsen SJ; Sun CH; Peng Q; Carper SW; Sioud M; Hirschberg H J Neurosurg; 2006 Jan; 104(1):109-17. PubMed ID: 16509154 [TBL] [Abstract][Full Text] [Related]
12. Modulation of migratory activity and invasiveness of human glioma spheroids following 5-aminolevulinic acid-based photodynamic treatment. Laboratory investigation. Etminan N; Peters C; Ficnar J; Anlasik S; Bünemann E; Slotty PJ; Hänggi D; Steiger HJ; Sorg RV; Stummer W J Neurosurg; 2011 Aug; 115(2):281-8. PubMed ID: 21513432 [TBL] [Abstract][Full Text] [Related]